Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-19 · accession 0002001162-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | 2025-11-19 | IPSC | Pfeiffenberger Brent | Pres, CEO, Dir | P - Purchase | $0.5 | +35.0K | 3.27M | +1% | +$17.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-19 | P | A | 35,000 | $0.5 | 3,271,453 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.488 to $0.5005. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. |